|
Oral Cancer |
|
Oral cancer accounts for 2% of all malignancies in the UK. Amongst the ten most common cancers worldwide. Over 90% of malignant neoplasms of the mouth are squamous cell carcinomas arising from mucosal surface epithelium. The remainder are adenocarcinomas of minor salivary glands and a few are undifferentiated or metastatic.
Epidemiology Approximately 2000 new cases of intraoral and lip carcinoma are registered each year in the UK. M>F at the moment, but this is changing. It is an age related disease, with 98% of patients > 40 years.
Aetiology Main aetiological factor in lip cancer is sunlight exposure. Causative associations have been made with tobacco, alcohol, betel quid, syphilis, candidosis, lichen planus, dysplastic lesions and oral submucous fibrosis. Causative factors operate over a long period and the process of malignant change is slow. Possible protective effect from diet rich in fresh fruits and vegetables and Vitamin A.
Site Nearly 30% of all oral cancer affects the lip - in some ways this can be regarded as a somewhat different disease to intra-oral carcinoma. The horseshoe shaped region, encompassing floor of mouth, lateral border of tongue and lingual sulcus, is where the majority of intra-oral cancer arises. (Unknown why..? pooling of carinogens in saliva)
Clinical appearance and Symptoms Of any of the following persisting for more than 3 weeks:-
Diagnositic tests Biopsy and histopathological examination, FNA of equivocal lymph nodes, plain radiography (DPT + CXR), computerized tomography (CT), magnetic resonance imaging (MRI), bone scintigraphy and ultrasound. Staging—TNM classification
Survival
Histopathology Characteristically squamous cell carcinoma shows invasion of deep tissues with cellular pleomorphism and hyperchromatism (increased nuclear staining). Spread can occur by local infiltration, lymphatics (cervical nodes) and late spread via blood stream. Bone initially forms a barrier, but is eventually destroyed, usually by superficial erosion.
Management
3. Chemotherapy
Prognosis for Intra-oral Carcinoma Stage I T1N0M0 85% survival rate at 5 years Stage II T2N0M0 65% survival rate at 5 years Stage III T3N0M0; T1/T2/T3N1M0 40% survival rate at 5 years Stage IV Any T4, N2, N3 or M1 10% survival rate at 5 years |
